Elsevier

Human Pathology

Volume 27, Issue 6, June 1996, Pages 599-604
Human Pathology

Original contribution
Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection

https://doi.org/10.1016/S0046-8177(96)90169-0Get rights and content

Abstract

To assess the utility of cytokeratin (CK) profile and albumin mRNA detection (as revealed by in situ hybridization) in the differential diagnosis of primary liver carcinomas (PLCs) we evaluated a series of surgically resected PLCs, comprising 20 “pure” hepatocellular carcinomas (HCCs) (10 well-differentiated, 10 poorly differentiated), 15 cholangiocarcinomas (CCs) (6 peripheral, 5 hilar, and 4 major duct ones) and 10 hepatocholangio-carcinomas (HCC-CCs). 11 of 20 (55%) of the pure HCCs expressed CKs of pure hepatocytic lineage (CK 8 and CK 18); 2 of 10 (20%) of the HCC-CCs displayed only hepatocytic profile, whereas 12 of 15 (80%) of the CCs evidenced mature bile duct cell phenotype (CK 8, CK 18, CK 7, CK 19). All HCCs expressed varying distributions of albumin mRNA, whereas 4 of 6 (67%) peripheral CCs showed cells with focal positivity for albumin mRNA. This suggests that the phenotypic expression of PLC cells are often not fixed, and in particular: (1) peripheral CCs have a different phenotype from hilar and large duct ones; (2) the CK profile and albumin mRNA expression in peripheral CCs show many similarities with those of some HCCs. Furthermore, the results show that a mixed biological phenotype (ie, CK 8, CK 18 and CK 7 and/ or CK 19) can be found both among morphologically pure HCCs and peripheral CCs, suggesting that these two forms could share a common histogenesis. We think that special attention should be given to cases in which CK profile and albumin mRNA reveal mixed phenotype, as these tumors could have different biological behavior and respond differently to therapy.

References (22)

  • P Van Eyken et al.

    Cytokeratin expression in hepatocellular carcinoma: An immunohistochemical study

    Hum Pathol

    (1988)
  • RA Allen et al.

    Combined liver cell and bile duct carcinoma

    Am J Pathol

    (1949)
  • ZD Goodman et al.

    Combined hepatocellular-cholangiocarcinoma: A histologic and immunohistochemical study

    Cancer

    (1985)
  • JB Gibson

    Histological typing of tumours of the liver, biliary tract and pancreas

  • Y Kondo

    Histologic features of hepatocellular carcinoma and allied disorders

    Ann Pathol

    (1985)
  • MA Gerber et al.

    Phenotypic characterization of hepatic proliferation: Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver

    Am J Pathol

    (1983)
  • A Chedid et al.

    Antigenic markers of hepatocellular carcinoma

    Cancer

    (1990)
  • DE Johnson et al.

    Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma

    Mod Pathol

    (1992)
  • DE Johnson et al.

    The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma

    Am J Surg Pathol

    (1988)
  • YS Lai et al.

    Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas

    Arch Pathol Lab Med

    (1989)
  • P Van Eyken et al.

    Immunocytochemistry of cytokeratins in primary human liver tumors

    APMIS Supp

    (1991)
  • Cited by (54)

    • Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma

      2011, Clinica Chimica Acta
      Citation Excerpt :

      Cytokeratins are present in many malignant epithelial original cells [9–11]. It has been reported that several cytokeratin subtypes are expressed in HCC [12] CK1 has the highest molecular weight and the highest isoelectric pH [13,14]. The aim of the present work is to evaluate the serum level of CK1 in patients with HCC associated with hepatitis C infection and to compare it with its level in patients with liver cirrhosis.

    View all citing articles on Scopus

    Supported by the CNR (Consiglio Nazionale di Ricerca), grants no. 92.02351PF39 and 92.02244PF39, and AIRC, Italy.

    1

    M. Fiorentino is a recipient of an AIRC grant.

    View full text